CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Alvarez Stauffer Bremer PLLC

Alvarez Stauffer Bremer PLLC is a full service law firm, located in downtown Houston, specializing in Pre-Litigation Disputes, Commercial Litigation, Energy Litigation, Mass Tort and Catastrophic Incident Litigation, Arbitration, and eDiscovery. ASB proudly represents international energy companies, large health-care and hospital systems, and pipeline operators — not to mention individuals and closely held companies.

科美(杭州)机械有限公司

Columbus Mckinnon is a New York-based company that manufactures and distributes material handling products including hoists and cranes for sectors such as food and utilities.

Polyram Plastic Industries Ltd

Polyram Plastic Industries Ltd is a leading international supplier of high-performance creative thermoplastic compounds, which used as raw materials in variety of markets. Polyram supplies both standard and customized thermoplastics in combination of glass fibers, glass beads and mineral fillers. The compounds are flame retardant, impact modified, heat stabilized, hydrolysis resistant and UV stabilized, with many other modifications available upon request. Polyram conforms to the highest quality control standards such as ISO/TS 16949 the internationally recognized standard of the automotive industry; NSF-61 & WRAS drinking water standards; and UL94 flammability standard. Polyrams focus is providing superior service and products for helping their customers develop and manufacture some of the most widely used products in the world.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.